ArticleClinical pharmacology and therapeutics2020

Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs.

Malidi Ahamadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.